Aggregated
42% success rate- Bullish
- 0
- Hold
- 0
- Bearish
- 0
BMO Capital
A BMO Capital analyst with 28 tracked ratings covering 12 distinct tickers has issued 20 bullish and 8 hold recommendations, focusing exclusively on one source.
Methodology differs by source. Track records are aggregated from multiple sources; scoring methodology and scales differ by source and values are not directly comparable. Coverage is sourced from publicly-aggregated analyst activity. Past performance does not guarantee future results. Not investment advice.
| Ticker | Date | Rating | Price target | Source |
|---|---|---|---|---|
| BNTX | 2026-03-11 | buy | $128.00 | Aggregated |
| SRRK | 2026-03-04 | buy | $70.00 | Aggregated |
| TERNTERNS PHARMACEUTICALS INC | 2025-11-04 | unknown | $22.00 | Aggregated |
| SRRK | 2025-08-07 | buy | $45.00 | Aggregated |
| ARVNARVINAS INC | 2025-03-12 | unknown | $20.00 | Aggregated |
| BNTXBIONTECH SE - ADR | 2025-03-11 | unknown | $143.00 | Aggregated |
| PTGXPROTAGONIST THERAPEUTICS INC | 2025-03-11 | unknown | $72.00 | Aggregated |
| MRUSMERUS N.V | 2025-02-28 | unknown | $96.00 | Aggregated |
| QTTB | 2025-02-11 | hold | $3.00 | Aggregated |
| IGMSIGM BIOSCIENCES INC | 2025-01-10 | unknown | $2.00 | Aggregated |
| EXELEXELIXIS INC | 2024-12-20 | unknown | $40.00 | Aggregated |
| QTTB | 2024-12-12 | buy | $22.00 | Aggregated |
| QTTBQ32 BIO INC. | 2024-12-12 | unknown | $22.00 | Aggregated |
| JSPRJASPER THERAPEUTICS INC | 2024-12-06 | unknown | $63.00 | Aggregated |
| KYMRKYMERA THERAPEUTICS INC | 2024-12-06 | unknown | $55.00 | Aggregated |
| NRIXNURIX THERAPEUTICS INC | 2024-12-06 | unknown | $35.00 | Aggregated |
| QTTB | 2024-12-06 | buy | $64.00 | Aggregated |
| TRMLTOURMALINE BIO INC | 2024-12-06 | unknown | $50.00 | Aggregated |
| ACRV | 2024-11-14 | buy | $27.00 | Aggregated |
| ACRVACRIVON THERAPEUTICS INC | 2024-11-14 | unknown | $27.00 | Aggregated |
| NUVL | 2024-11-13 | buy | $134.00 | Aggregated |
| NUVLNUVALENT INC - ORDINARY SHARES - CLASS A | 2024-11-13 | unknown | $134.00 | Aggregated |
| GMAB | 2024-11-08 | buy | $48.00 | Aggregated |
| XNCR | 2024-11-08 | buy | $34.00 | Aggregated |
| NVS | 2024-10-30 | hold | $120.00 | Aggregated |
| NVSNOVARTIS AG - ADR | 2024-10-30 | unknown | $120.00 | Aggregated |
| ACRV | 2024-09-16 | buy | $28.00 | Aggregated |
| YMABY-MABS THERAPEUTICS INC | 2024-08-13 | unknown | $25.00 | Aggregated |
| MGNX | 2024-08-07 | hold | $5.00 | Aggregated |
| MGNXMACROGENICS INC | 2024-08-07 | unknown | $5.00 | Aggregated |
| CCCC | 2024-08-06 | buy | $20.00 | Aggregated |
| CCCCC4 THERAPEUTICS INC | 2024-08-06 | unknown | $20.00 | Aggregated |
| XNCR | 2024-08-06 | buy | $32.00 | Aggregated |
| XNCRXENCOR INC | 2024-08-06 | unknown | $32.00 | Aggregated |
| XNCR | 2024-06-14 | buy | $32.00 | Aggregated |
| SRRKSCHOLAR ROCK HOLDING CORP | 2024-06-13 | unknown | $31.00 | Aggregated |
| ACRV | 2024-05-15 | buy | $25.00 | Aggregated |
| FATE | 2024-05-10 | hold | $6.00 | Aggregated |
| MGNX | 2024-05-10 | hold | $8.00 | Aggregated |
| CTMXCYTOMX THERAPEUTICS INC | 2024-05-01 | unknown | $3.25 | Aggregated |
| ACRV | 2024-04-26 | buy | $25.00 | Aggregated |
| AZN | 2024-04-26 | buy | $82.00 | Aggregated |
| NVS | 2024-04-24 | hold | $116.00 | Aggregated |
| ACRV | 2024-04-01 | buy | $18.00 | Aggregated |
| FATE | 2024-02-27 | hold | $7.00 | Aggregated |
| FATEFATE THERAPEUTICS INC | 2024-02-27 | unknown | $7.00 | Aggregated |
| GMABGENMAB - ADR | 2024-02-23 | unknown | $48.00 | Aggregated |
| NVS | 2024-02-23 | hold | $114.00 | Aggregated |
| AZN | 2024-02-12 | buy | $80.00 | Aggregated |
| CCCC | 2023-11-03 | buy | $16.00 | Aggregated |
| Ticker | Ratings | Last rating | Sources |
|---|---|---|---|
| BNTX | 1 | 2026-03-11 | Aggregated |
| SRRK | 2 | 2026-03-04 | Aggregated |
| TERNTERNS PHARMACEUTICALS INC | 1 | 2025-11-04 | Aggregated |
| ARVNARVINAS INC | 1 | 2025-03-12 | Aggregated |
| BNTXBIONTECH SE - ADR | 1 | 2025-03-11 | Aggregated |
| PTGXPROTAGONIST THERAPEUTICS INC | 1 | 2025-03-11 | Aggregated |
| MRUSMERUS N.V | 1 | 2025-02-28 | Aggregated |
| QTTB | 3 | 2025-02-11 | Aggregated |
| IGMSIGM BIOSCIENCES INC | 1 | 2025-01-10 | Aggregated |
| EXELEXELIXIS INC | 1 | 2024-12-20 | Aggregated |
| QTTBQ32 BIO INC. | 1 | 2024-12-12 | Aggregated |
| JSPRJASPER THERAPEUTICS INC | 1 | 2024-12-06 | Aggregated |
| KYMRKYMERA THERAPEUTICS INC | 1 | 2024-12-06 | Aggregated |
| NRIXNURIX THERAPEUTICS INC | 1 | 2024-12-06 | Aggregated |
| TRMLTOURMALINE BIO INC | 1 | 2024-12-06 | Aggregated |
| ACRV | 5 | 2024-11-14 | Aggregated |
| ACRVACRIVON THERAPEUTICS INC | 1 | 2024-11-14 | Aggregated |
| NUVL | 1 | 2024-11-13 | Aggregated |
| NUVLNUVALENT INC - ORDINARY SHARES - CLASS A | 1 | 2024-11-13 | Aggregated |
| GMAB | 1 | 2024-11-08 | Aggregated |
| XNCR | 3 | 2024-11-08 | Aggregated |
| NVS | 3 | 2024-10-30 | Aggregated |
| NVSNOVARTIS AG - ADR | 1 | 2024-10-30 | Aggregated |
| YMABY-MABS THERAPEUTICS INC | 1 | 2024-08-13 | Aggregated |
| MGNX | 2 | 2024-08-07 | Aggregated |
| MGNXMACROGENICS INC | 1 | 2024-08-07 | Aggregated |
| CCCC | 2 | 2024-08-06 | Aggregated |
| CCCCC4 THERAPEUTICS INC | 1 | 2024-08-06 | Aggregated |
| XNCRXENCOR INC | 1 | 2024-08-06 | Aggregated |
| SRRKSCHOLAR ROCK HOLDING CORP | 1 | 2024-06-13 | Aggregated |
| FATE | 2 | 2024-05-10 | Aggregated |
| CTMXCYTOMX THERAPEUTICS INC | 1 | 2024-05-01 | Aggregated |
| AZN | 3 | 2024-04-26 | Aggregated |
| FATEFATE THERAPEUTICS INC | 1 | 2024-02-27 | Aggregated |
| GMABGENMAB - ADR | 1 | 2024-02-23 | Aggregated |
| AZNASTRAZENECA PLC - ADR | 1 | 2023-08-01 | Aggregated |
| FHTXFOGHORN THERAPEUTICS INC | 1 | 2023-04-25 | Aggregated |